All terms
ISO 10993-1
Biological evaluation of medical devices within a risk management process.
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026
Definition
ISO 10993-1:2018 describes the general principles governing the biological evaluation of medical devices within a risk management process, including selection of evaluation tests based on tissue contact and duration. What the regulation says
ISO 10993-1:2018 outlines a structured approach to biological evaluation as part of a risk management process, emphasizing that biocompatibility assessment should consider the nature and duration of device contact with the body. The FDA recognizes ISO 10993-1:2018, often supplementing it with specific FDA guidance documents, such as the "Use of International Standard ISO 10993-1, What this means in practice
Biocompatibility documentation is a routine requirement for any patient-contacting device. FDA's recognized version aligns with ISO 10993-1:2018 plus FDA-specific guidance.Examples
- A manufacturer of an implantable bone screw uses ISO 10993-1 to determine the necessary biological tests, including cytotoxicity, sensitization, and implantation studies, based on its permanent tissue contact.
- For a single-use external bandage, a company applies the principles of ISO 10993-1 to justify conducting only cytotoxicity and skin irritation tests, considering its limited skin contact duration.
- When redesigning a catheter with a new coating, a company refers to ISO 10993-1 to reassess biocompatibility implications and identifies the need for additional material characterization and systemic toxicity tests.
Common pitfalls
- •Failing to integrate biocompatibility evaluation into the overall risk management process can lead to overlooked hazards.
- •Selecting inappropriate test methods based on incorrect assumptions about device contact or duration can result in inadequate biological evaluation.
- •Not considering the manufacturing process and its potential impact on the device's biocompatibility can lead to non-conformance.
- •Ignoring changes in device materials or intended use can invalidate previous biocompatibility assessments.
- •Solely relying on material certificates without conducting device-specific testing when necessary is a common pitfall.
Frequently asked questions
The primary purpose is to establish general principles for the biological evaluation of MedTech devices, ensuring their safety regarding interaction with biological systems. It guides the selection of appropriate tests based on risk assessment.
Related terms
Shared paths + categoryQuality & Risk
Biocompatibility
Ability of a material to perform with an appropriate host response in a specific application.
Manufacturing & Supply Chain · adjacent
Standards
ISO 11135
Standard for development, validation, and routine control of ethylene oxide (EO) sterilization.
Standards Stack for Medical Devices · adjacentManufacturing & Supply Chain · adjacent
Standards
IEC 62366-1
Application of usability engineering to medical devices.
Standards Stack for Medical Devices · adjacent
Standards
IEC 60601-1
General requirements for basic safety and essential performance of medical electrical equipment.
Standards Stack for Medical Devices
Standards
IEC 60601-1-2
EMC requirements for medical electrical equipment.
Standards Stack for Medical Devices
Standards
IEC 62304
Lifecycle requirements for medical device software.
Standards Stack for Medical Devices
Latest in MedTech
Primary references
3 sourcesLink health: 3 verified· last checked 2026-06-20
ISO·2IEC·1
- 1ISO 10993-1:2018VerifiedISOiso.org
- 2ISO Standards Catalogue - HealthVerifiedISOiso.org
- 3IEC Webstore - Medical EquipmentVerifiedIECwebstore.iec.ch
Inline markers like [1] jump to the matching reference above.